Stockreport

Nkarta to Participate in an Upcoming Investor Conference

Nkarta, Inc.  (NKTX) 
PDF SOUTH SAN FRANCISCO, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell [Read more]